Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dorra Jabr1, Roua Hsasna1, Salma Kefi1

  • 1Clinical Hematology Department, Aziza Othmana Hospital, Faculty of Medicine of Tunis, University of Tunis el Manar, Tunis, Tunisia.

La Tunisie Medicale
|June 12, 2024
PubMed
Summary

Plasma exchange (PE) is crucial for treating thrombotic thrombocytopenic purpura (TTP). Daily PE and a drop in LDH levels by day 5 predict treatment success, though refractory cases may require additional therapies like rituximab.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chemotherapy-induced febrile neutropenia in acute myeloblastic leukemia: A single-center study of adult patients.

La Tunisie medicale·2026
Same author

Management of Philadelphia chromosome-positive B-acute lymphoblastic leukemia in Tunisia.

La Tunisie medicale·2026
Same author

Primary Gastric Hodgkin Lymphoma: A Case Report.

Middle East journal of digestive diseases·2026
Same author

Therapeutic outcomes of acute promyelocytic leukemia in children.

Leukemia research reports·2026
Same author

Ultimate Pre-Transfusion Bedside Check: Evaluation of Hospital Staff.

La Tunisie medicale·2026
Same author

Cytomegalovirus reactivation risk after autologous hematopoietic stem cell transplantation: Results of a Tunisian study.

World journal of virology·2026

Area of Science:

  • Hematology
  • Internal Medicine
  • Clinical Research

Context:

  • Thrombotic thrombocytopenic purpura (TTP) is a rare, life-threatening hematological disorder.
  • Immediate treatment with plasma exchange (PE) is critical upon diagnosis.

Purpose:

  • To evaluate the efficacy and safety of plasma exchange (PE) in treating TTP.
  • To identify factors associated with treatment response and complications.

Summary:

  • A retrospective study of 26 TTP patients treated with PE showed a 69% overall response rate.
  • Daily PE and a decrease in lactate dehydrogenase (LDH) by day 5 were linked to successful treatment.
  • Hypocalcemia was the most common PE-related complication; 30% mortality was observed.

Impact:

Keywords:
PlasmapheresisSurvivalThrombotic microangiopathiesThrombotic thrombocytopenic purpura

Related Experiment Videos

  • The study highlights PE's role in TTP management but notes a higher-than-literature rate of refractory disease.
  • Findings suggest rituximab could potentially improve outcomes in refractory TTP cases.
  • Identifies key indicators for treatment success and potential complications, aiding clinical decision-making.